LEVAQUIN (levofloxacin) Janssen pharms Patent: 6,806,256 Expiration: Aug 26, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Drug …
Drug Patent Expirations for the Week of August 21, 2022 Read Post »
Annual Drug Patent Expirations for FINTEPLA Fintepla is a drug marketed by Zogenix Inc and is included in one NDA. It is available from one supplier. There are eleven patents…
The post New patent for Zogenix Inc drug FINTEPLA appeared first on DrugPate…
Annual Drug Patent Expirations for QINLOCK Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. There are seven patents protecting this drug. This drug has…
The post New patent for Deciphera Pharms drug QINLOCK appeared first on D…
Annual Drug Patent Expirations for CABENUVA+KIT Cabenuva Kit is a drug marketed by Viiv Hlthcare and is included in one NDA. It is available from one supplier. There are five…
The post New patent for Viiv Hlthcare drug CABENUVA KIT appeared first on Dr…
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Novartis drug SCEMBLIX appeared first on DrugPate…
Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There is one patent protecting…
The post New patent for Novartis drug SCEMBLIX appeared first on DrugPate…
Annual Drug Patent Expirations for DROSPIRENONE Drospirenone is a drug marketed by Exeltis Usa Inc, Barr, Glenmark Pharms Ltd, Hetero Labs Ltd, Hlthcare, Jubilant Cadista, Mylan Labs Ltd, Watson Labs,…
The post New patent for Exeltis Usa drug DROSPIREN…
Annual Drug Patent Expirations for ARISTADA Aristada is a drug marketed by Alkermes Inc and is included in two NDAs. It is available from one supplier. There are sixteen patents…
The post New patent for Alkermes Inc drug ARISTADA appeared first on Drug…
Annual Drug Patent Expirations for SLYND Slynd is a drug marketed by Exeltis Usa Inc and is included in one NDA. There are nine patents protecting this drug. SLYND drug…
The post New patent for Exeltis Usa drug SLYND appeared first on DrugPatentWatch -…
Annual Drug Patent Expirations for FIRDAPSE Firdapse is a drug marketed by Catalyst Pharms and is included in one NDA. It is available from one supplier. There are five patents…
The post New patent for Catalyst Pharms drug FIRDAPSE appeared first on Dr…
Get new actionable insights and updates from BiotechBlog
